The dangerous second life of medical waste
Beyond the more apparent environmental challenges of rising medical waste from at-home injectables like Glucagon-like peptide-1 (GLP-1) agonists, pharmaceutical companies…
29 Apr 2024
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
US lawmakers have added more Chinese biotech and medtech companies to the list of firms posing national security risks that they are seeking to prevent doing business with the US.…
21 Dec 2023
The curtain closes on a successful World Investment Conference in New Delhi
NEW DELHI – The World Investment Conference (WIC) 2023, the annual meeting of the World Association of Investment Promotion Agencies (WAIPA), has concluded in New Delhi after an action-packed four…
09 Nov 2023
Cloud in pharma: Q&A with GlobalData thematic analyst
Jemima Walker is a healthcare analyst in GlobalData’s Thematic Intelligence team. Her expertise lies in the healthcare industry and in themes including cloud, robotics, ecommerce, healthtech, and cybersecurity. Lara Virrey:…
24 Oct 2023
AI in pharma: Q&A with GlobalData thematic analyst
Maddy Irwin joined GlobalData's Thematic Intelligence team in September 2022. She is particularly interested in analysing how tech themes affect the healthcare industry. Lara Virrey: What are the most exciting…
11 Oct 2023
Cybersecurity in pharma: Q&A with GlobalData thematic analyst
Wafaa Hasan, MSc, is a senior digital health and thematic analyst in the pharma team at GlobalData. Her responsibilities involve writing reports and providing insights on digital strategy across disease…
25 Sep 2023
Germany needs a new economic business model
During the onset of Russia’s full-scale invasion of Ukraine, Germany experienced its definitive boiling frog moment. Former chancellor Angela Merkel’s 16 years of incrementalism appeared to have successfully disguised the…